[1]. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596

[2]. WHO. (2022). Schizophrenia. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/schizophrenia

[3]. Rasool, S., ZeeshanZafar, M., Ali, Z., & Erum, A. (2018). Schizophrenia: An overview. Clinical Practice, 15(5). https://doi.org/10.4172/clinical-practice.1000417

[4]. DeVylder, J. E. (2016). Preventing Schizophrenia and Severe Mental Illness: A Grand Challenge for Social Work. Research on Social Work Practice, 26(4), 449–459. https://doi.org/10.1177/1049731515622687

[5]. Waro, M. C., & Fitrikasari, A. (2021). Profile of Schizophrenia Aggressiveness with the Risk of Suicide based on the Personality and Social Performance Score. Scientia Psychiatrica, 2(1), Article 1. https://doi.org/10.37275/scipsy.v2i1.27

[6]. Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., Lam, M., Watanabe, K., Frei, O., Ge, T., Harwood, J. C., Koopmans, F., Magnusson, S., Richards, A. L., Sidorenko, J., … O’Donovan, M. C. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502–508. https://doi.org/10.1038/s41586-022-04434-5

[7]. Brown, A. S. (2011). The environment and susceptibility to schizophrenia. Progress in Neurobiology, 93(1), 23–58. https://doi.org/10.1016/j.pneurobio.2010.09.003

[8]. Jauhar, S., Johnstone, M., & McKenna, P. J. (2022). Schizophrenia. The Lancet, 399(10323), 473–486. https://doi.org/10.1016/S0140-6736(21)01730-X

[9]. Murray, R. M., Bhavsar, V., Tripoli, G., & Howes, O. (2017). 30 Years on: How the Neurodevelopmental Hypothesis of Schizophrenia Morphed Into the Developmental Risk Factor Model of Psychosis. Schizophrenia Bulletin, 43(6), 1190–1196. https://doi.org/10.1093/schbul/sbx121

[10]. McCullumsmith, R. E., Clinton, S. M., & Meador-Woodruff, J. H. (2004). Schizophrenia as a Disorder of Neuroplasticity. In International Review of Neurobiology (Vol. 59, pp. 19–45). Academic Press. https://doi.org/10.1016/S0074-7742(04)59002-5

[11]. Arnold, S. E., Talbot, K., & Hahn, C.-G. (2005). Neurodevelopment, neuroplasticity, and new genes for schizophrenia. In Progress in Brain Research (Vol. 147, pp. 319–345). Elsevier. https://doi.org/10.1016/S0079-6123(04)47023-X

[12]. Vinogradov, S., Chafee, M. V., Lee, E., & Morishita, H. (2023). Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity. Neuropsychopharmacology, 48(1), 168–185. https://doi.org/10.1038/s41386-022-01451-w

[13]. Tran The, J., Magistretti, P. J., & Ansermet, F. (2022). The critical periods of cerebral plasticity: A key aspect in a dialog between psychoanalysis and neuroscience centered on the psychopathology of schizophrenia. Frontiers in Molecular Neuroscience, 15. https://doi.org/10.3389/fnmol.2022.1057539

[14]. Bhandari, A., Voineskos, D., Daskalakis, Z. J., Rajji, T. K., & Blumberger, D. M. (2016). A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation. Frontiers in Psychiatry, 7. https://doi.org/10.3389/fpsyt.2016.00045

[15]. Balu, D. T., & Coyle, J. T. (2011). Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neuroscience & Biobehavioral Reviews, 35(3), 848–870. https://doi.org/10.1016/j.neubiorev.2010.10.005

[16]. Fatemi, S. H., & Folsom, T. D. (2009). The Neurodevelopmental Hypothesis of Schizophrenia, Revisited. Schizophrenia Bulletin, 35(3), 528–548. https://doi.org/10.1093/schbul/sbn187

[17]. Selemon, L. D., & Zecevic, N. (2015). Schizophrenia: A tale of two critical periods for prefrontal cortical development. Translational Psychiatry, 5(8), e623–e623. https://doi.org/10.1038/tp.2015.115

[18]. Murray, R. M., Bora, E., Modinos, G., & Vernon, A. (2022). Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline. Schizophrenia Research, 243, 181–186. https://doi.org/10.1016/j.schres.2022.03.005

[19]. Birnbaum, R., & Weinberger, D. R. (2017). Genetic insights into the neurodevelopmental origins of schizophrenia. Nature Reviews Neuroscience, 18(12), 727–740. https://doi.org/10.1038/nrn.2017.125

[20]. Schepanski, S., Buss, C., Hanganu-Opatz, I. L., & Arck, P. C. (2018). Prenatal Immune and Endocrine Modulators of Offspring’s Brain Development and Cognitive Functions Later in Life. Frontiers in Immunology, 9. https://doi.org/10.3389/fimmu.2018.02186

[21]. Khandaker, G. M., Zimbron, J., Lewis, G., & Jones, P. B. (2013). Prenatal maternal infection, neurodevelopment and adult schizophrenia: A systematic review of population-based studies. Psychological Medicine, 43(2), 239–257. https://doi.org/10.1017/S0033291712000736

[22]. Brown, A. S. (2006). Prenatal Infection as a Risk Factor for Schizophrenia. Schizophrenia Bulletin, 32(2), 200–202. https://doi.org/10.1093/schbul/sbj052

[23]. Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004). Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia. ARCH GEN PSYCHIATRY, 61.

[24]. Clarke, M. C., Tanskanen, A., Huttunen, M., Whittaker, J. C., & Cannon, M. (2009). Evidence for an Interaction Between Familial Liability and Prenatal Exposure to Infection in the Causation of Schizophrenia. Am J Psychiatry.

[25]. Brown, A. S. (2011). Exposure to Prenatal Infection and Risk of Schizophrenia. Frontiers in Psychiatry, 2. https://doi.org/10.3389/fpsyt.2011.00063

[26]. Brown, A. S., & Meyer, U. (2018). Maternal Immune Activation and Neuropsychiatric Illness: A Translational Research Perspective. American Journal of Psychiatry, 175(11), 1073–1083. https://doi.org/10.1176/appi.ajp.2018.17121311

[27]. Cheslack-Postava, K., & Brown, A. S. (2022). Prenatal infection and schizophrenia: A decade of further progress. Schizophrenia Research, 247, 7–15. https://doi.org/10.1016/j.schres.2021.05.014

[28]. Oh-Nishi, A., Obayashi, S., Sugihara, I., Minamimoto, T., & Suhara, T. (2010). Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring. Brain Research, 1363, 170–179. https://doi.org/10.1016/j.brainres.2010.09.054

[29]. Blomström, Å., Karlsson, H., Wicks, S., Yang, S., Yolken, R. H., & Dalman, C. (2012). Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring—A matched case–control study. Schizophrenia Research, 140(1–3), 25–30. https://doi.org/10.1016/j.schres.2012.06.035

[30]. Mortensen, P. B., Pedersen, C. B., Hougaard, D. M., Nørgaard-Petersen, B., Mors, O., Børglum, A. D., & Yolken, R. H. (2010). A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophrenia Research, 122(1–3), 257–263. https://doi.org/10.1016/j.schres.2010.06.010

[31]. Brown, A. S., & Susser, E. S. (2008). Prenatal Nutritional Deficiency and Risk of Adult Schizophrenia. Schizophrenia Bulletin, 34(6), 1054–1063. https://doi.org/10.1093/schbul/sbn096

[32]. Freedman, R., Hunter, S. K., & Hoffman, M. C. (2018). Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy. American Journal of Psychiatry, 175(7), 607–619. https://doi.org/10.1176/appi.ajp.2018.17070836

[33]. Hoek, H. W., Brown, A. S., & Susser, E. (1998). The Dutch Famine and schizophrenia spectrum disorders. Social Psychiatry and Psychiatric Epidemiology, 33(8), 373–379. https://doi.org/10.1007/s001270050068

[34]. He, P., Chen, G., Guo, C., Wen, X., Song, X., & Zheng, X. (2018). Long-term effect of prenatal exposure to malnutrition on risk of schizophrenia in adulthood: Evidence from the Chinese famine of 1959–1961. European Psychiatry, 51, 42–47. https://doi.org/10.1016/j.eurpsy.2018.01.003

[35]. Brown, A. S., Susser, E. S., Butler, P. D., Andrews, R. R., Kaufmann, C. A., & Gorman, J. M. (1996). Neurobiological Plausibility of Prenatal Nutritional Deprivation as a Risk Factor for Schizophrenia. The Journal of Nervous and Mental Disease, 184(2), 71.

[36]. Hulshoff Pol, H. E., Hoek, H. W., Susser, E., Brown, A. S., Dingemans, A., Schnack, H. G., van Haren, N. E. M., Pereira Ramos, L. M., Gispen-de Wied, C. C., & Kahn, R. S. (2000). Prenatal Exposure to Famine and Brain Morphology in Schizophrenia. American Journal of Psychiatry, 157(7), 1170–1172. https://doi.org/10.1176/appi.ajp.157.7.1170

[37]. Maxwell, A. M., & Rao, R. B. (2022). Perinatal iron deficiency as an early risk factor for schizophrenia. Nutritional Neuroscience, 25(10), 2218–2227. https://doi.org/10.1080/1028415X.2021.1943996

[38]. Zammit, S., Lewis, S., Gunnell, D., & Smith, G. D. (2007). Schizophrenia and Neural Tube Defects: Comparisons From an Epidemiological Perspective. Schizophrenia Bulletin, 33(4), 853–858. https://doi.org/10.1093/schbul/sbl041

[39]. Abrahamyan Empson, L., Baumann, P. S., Söderström, O., Codeluppi, Z., Söderström, D., & Conus, P. (2020). Urbanicity: The need for new avenues to explore the link between urban living and psychosis. Early Intervention in Psychiatry, 14(4), 398–409. https://doi.org/10.1111/eip.12861

[40]. Haddad, L., Schafer, A., Streit, F., Lederbogen, F., Grimm, O., Wust, S., Deuschle, M., Kirsch, P., Tost, H., & Meyer-Lindenberg, A. (2015). Brain Structure Correlates of Urban Upbringing, an Environmental Risk Factor for Schizophrenia. Schizophrenia Bulletin, 41(1), 115–122. https://doi.org/10.1093/schbul/sbu072

[41]. McKenzie, K., Murray, A., & Booth, T. (2013). Do urban environments increase the risk of anxiety, depression and psychosis? An epidemiological study. Journal of Affective Disorders, 150(3), 1019–1024. https://doi.org/10.1016/j.jad.2013.05.032

[42]. Marcelis, M., Takei, N., & Van Os, J. (1999). Urbanization and risk for schizophrenia: Does the effect operate before or around the time of illness onset? Psychological Medicine, 29(5), 1197–1203. https://doi.org/10.1017/S0033291799008983

[43]. Jaaro-Peled, H., & Sawa, A. (2020). Neurodevelopmental Factors in Schizophrenia. Psychiatric Clinics of North America, 43(2), 263–274. https://doi.org/10.1016/j.psc.2020.02.010

[44]. Kirkbride, J. B., & Jones, P. B. (2011). The Prevention of Schizophrenia—What Can We Learn From Eco-Epidemiology? Schizophrenia Bulletin, 37(2), 262–271. https://doi.org/10.1093/schbul/sbq120

[45]. Costa E Silva, J. A., & Steffen, R. E. (2019). Urban environment and psychiatric disorders: A review of the neuroscience and biology. Metabolism, 100, 153940. https://doi.org/10.1016/j.metabol.2019.07.004

[46]. Söderström, O., Empson, L. A., Codeluppi, Z., Söderström, D., Baumann, P. S., & Conus, P. (2016). Unpacking ‘the City’: An experience-based approach to the role of urban living in psychosis. Health & Place, 42, 104–110. https://doi.org/10.1016/j.healthplace.2016.09.002

[47]. Howes, O. D., & Murray, R. M. (2014). Schizophrenia: An integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677–1687. https://doi.org/10.1016/S0140-6736(13)62036-X

[48]. Aas, M., Dazzan, P., Mondelli, V., Melle, I., Murray, R. M., & Pariante, C. M. (2014). A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation. Frontiers in Psychiatry, 4. https://doi.org/10.3389/fpsyt.2013.00182

[49]. Vargas, T., Lam, P. H., Azis, M., Osborne, K. J., Lieberman, A., & Mittal, V. A. (2019). Childhood Trauma and Neurocognition in Adults With Psychotic Disorders: A Systematic Review and Meta-analysis. Schizophrenia Bulletin, 45(6), 1195–1208. https://doi.org/10.1093/schbul/sby150

[50]. Inyang, B., Gondal, F. J., Abah, G. A., Minnal Dhandapani, M., Manne, M., Khanna, M., Challa, S., Kabeil, A. S., & Mohammed, L. (2022). The Role of Childhood Trauma in Psychosis and Schizophrenia: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.21466

[51]. Read, J., Fosse, R., Moskowitz, A., & Perry, B. (2014). The traumagenic neurodevelopmental model of psychosis revisited. Neuropsychiatry, 4(1), 65–79. https://doi.org/10.2217/npy.13.89

[52]. Cancel, A., Dallel, S., Zine, A., El-Hage, W., & Fakra, E. (2019). Understanding the link between childhood trauma and schizophrenia: A systematic review of neuroimaging studies. Neuroscience & Biobehavioral Reviews, 107, 492–504. https://doi.org/10.1016/j.neubiorev.2019.05.024

[53]. Holtzman, C. W., Trotman, H. D., Goulding, S. M., Ryan, A. T., MacDonald, A. N., Shapiro, D. I., Brasfield, J. L., & Walker, E. F. (2013). Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience, 249, 172–191. https://doi.org/10.1016/j.neuroscience.2012.12.017

[54]. Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005). Childhood trauma, psychosis and schizophrenia: A literature review with theoretical and clinical implications. Acta Psychiatrica Scandinavica, 112(5), 330–350. https://doi.org/10.1111/j.1600-0447.2005.00634.x

[55]. Ruby, E., Polito, S., McMahon, K., Gorovitz, M., Corcoran, C., & Malaspina, D. (2014). Pathways Associating Childhood Trauma to the Neurobiology of Schizophrenia. Frontiers in Psychological and Behavioral Science, 3(1), 1–17.

[56]. Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018). Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis. Drug and Alcohol Dependence, 191, 234–258. https://doi.org/10.1016/j.drugalcdep.2018.07.011

[57]. Yücel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., Conus, P., Takagi, M. J., Fornito, A., Wood, S. J., McGorry, P. D., & Pantelis, C. (2012). The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample. Schizophrenia Bulletin, 38(2), 316–330. https://doi.org/10.1093/schbul/sbq079

[58]. Khokhar, J. Y., Dwiel, L. L., Henricks, A. M., Doucette, W. T., & Green, A. I. (2018). The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research, 194, 78–85. https://doi.org/10.1016/j.schres.2017.04.016

[59]. Margolese, H. C., Malchy, L., Negrete, J. C., Tempier, R., & Gill, K. (2004). Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences. Schizophrenia Research, 67(2–3), 157–166. https://doi.org/10.1016/S0920-9964(02)00523-6

[60]. Asher, C. J., & Gask, L. (2010). Reasons for illicit drug use in people with schizophrenia: Qualitative study. BMC Psychiatry, 10(1), 94. https://doi.org/10.1186/1471-244X-10-94

[61]. Green, A. I. (2005). Schizophrenia and comorbid substance use disorder: Effects of antipsychotics. The Journal of Clinical Psychiatry, 66 Suppl 6, 21–26.

[62]. Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2000). The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia. Schizophrenia Bulletin, 26(2), 441–449. https://doi.org/10.1093/oxfordjournals.schbul.a033464

[63]. Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Samara, M., Rabaioli, M., Bächer, S., Cipriani, A., Geddes, J. R., Salanti, G., & Davis, J. M. (2017). Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry, 174(10), 927–942. https://doi.org/10.1176/appi.ajp.2017.16121358

[64]. Lally, J., & MacCabe, J. H. (2015). Antipsychotic medication in schizophrenia: A review. British Medical Bulletin, 114(1), 169–179. https://doi.org/10.1093/bmb/ldv017

[65]. De Peri, L., Deste, G., & Vita, A. (2021). Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed. Psychiatry Research, 301, 113962. https://doi.org/10.1016/j.psychres.2021.113962

[66]. Mcguire, P., Howes, O., Stone, J., & Fusarpoli, P. (2008). Functional neuroimaging in schizophrenia: Diagnosis and drug discovery. Trends in Pharmacological Sciences, 29(2), 91–98. https://doi.org/10.1016/j.tips.2007.11.005[66] Mcguire, P., Howes, O., Stone, J., & Fusarpoli, P. (2008). Functional neuroimaging in schizophrenia: Diagnosis and drug discovery. Trends in Pharmacological Sciences, 29(2), 91–98. https://doi.org/10.1016/j.tips.2007.11.005

[67]. Frangou, S., & Murray, R. M. (1996). Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. British Medical Bulletin, 52(3), 587–596. https://doi.org/10.1093/oxfordjournals.bmb.a011569

[68]. Baribeau, D. A., & Anagnostou, E. (2013). A Comparison of Neuroimaging Findings in Childhood Onset Schizophrenia and Autism Spectrum Disorder: A Review of the Literature. Frontiers in Psychiatry, 4. https://doi.org/10.3389/fpsyt.2013.00175

[69]. Howes, O. D., Cummings, C., Chapman, G. E., & Shatalina, E. (2023). Neuroimaging in schizophrenia: An overview of findings and their implications for synaptic changes. Neuropsychopharmacology, 48(1), 151–167. https://doi.org/10.1038/s41386-022-01426-x[69] Howes, O. D., Cummings, C., Chapman, G. E., & Shatalina, E. (2023). Neuroimaging in schizophrenia: An overview of findings and their implications for synaptic changes. Neuropsychopharmacology, 48(1), 151–167. https://doi.org/10.1038/s41386-022-01426-x

[70]. Sugranyes, G., De La Serna, E., Borras, R., Sanchez-Gistau, V., Pariente, J. C., Romero, S., Baeza, I., Díaz-Caneja, C. M., Rodriguez-Toscano, E., Moreno, C., Bernardo, M., Moreno, D., Vieta, E., & Castro-Fornieles, J. (2017). Clinical, Cognitive, and Neuroimaging Evidence of a Neurodevelopmental Continuum in Offspring of Probands With Schizophrenia and Bipolar Disorder. Schizophrenia Bulletin, 43(6), 1208–1219. https://doi.org/10.1093/schbul/sbx002

[71]. Kraguljac, N. V., McDonald, W. M., Widge, A. S., Rodriguez, C. I., Tohen, M., & Nemeroff, C. B. (2021). Neuroimaging Biomarkers in Schizophrenia. American Journal of Psychiatry, 178(6), 509–521. https://doi.org/10.1176/appi.ajp.2020.20030340

[72]. Tarcijonas, G., & Sarpal, D. K. (2019). Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies. Neurobiology of Disease, 131, 104209. https://doi.org/10.1016/j.nbd.2018.06.021

[73]. Campos, C., Santos, S., Gagen, E., Machado, S., Rocha, S., Kurtz, M. M., & Rocha, N. B. (2016). Neuroplastic Changes Following Social Cognition Training in Schizophrenia: A Systematic Review. Neuropsychology Review, 26(3), 310–328. https://doi.org/10.1007/s11065-016-9326-0